Atossa Genetics Debt to Equity Ratio 2012-2019 | ATOS

Current and historical debt to equity ratio values for Atossa Genetics (ATOS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Atossa Genetics debt/equity for the three months ending March 31, 2019 was 0.00.
Atossa Genetics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-03-31 $0.00B $0.02B 0.00
2018-12-31 $0.00B $0.01B 0.00
2018-09-30 $0.00B $0.01B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.01B 0.00
2016-06-30 $0.00B $0.00B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.01B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.01B 0.00
2014-12-31 $0.00B $0.01B 0.00
2014-09-30 $0.00B $0.02B 0.00
2014-06-30 $0.00B $0.02B 0.00
2014-03-31 $0.00B $0.02B 0.00
2013-12-31 $0.00B $0.01B 0.00
2013-09-30 $0.00B $0.01B 0.00
2013-06-30 $0.00B $0.01B 0.00
2013-03-31 $0.00B $0.01B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.019B $0.000B
Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.099B 24.96
Intuitive Surgical (ISRG) United States $57.325B 52.82
Edwards Lifesciences (EW) United States $38.350B 38.32
IDEXX Laboratories (IDXX) United States $23.038B 60.44
Fresenius Medical Care AG KGaA (FMS) Germany $22.958B 15.08
Teleflex (TFX) United States $14.780B 32.02
DexCom (DXCM) United States $13.479B 264.36
Hologic (HOLX) United States $12.824B 20.62
Varian Medical Systems (VAR) United States $11.903B 30.37
STERIS (STE) Ireland $11.874B 28.72
ABIOMED (ABMD) United States $11.325B 69.13
Masimo (MASI) United States $7.525B 46.10
Penumbra (PEN) United States $5.795B 245.34
Integra LifeSciences Holdings (IART) United States $4.349B 20.43
Globus Medical (GMED) United States $4.078B 25.43
Wright Medical Group (WMGI) Netherlands $3.945B 782.00
Tandem Diabetes Care (TNDM) United States $3.692B 0.00
LivaNova (LIVN) United Kingdom $3.548B 23.13
Cantel Medical (CMD) United States $3.187B 32.33
Glaukos (GKOS) United States $2.669B 0.00
Integer Holdings (ITGR) United States $2.549B 18.79
AVANOS MEDICAL, INC (AVNS) United States $2.054B 32.51
Nevro (NVRO) United States $1.920B 0.00
ShockWave Medical (SWAV) United States $1.630B 0.00
Inogen (INGN) United States $1.491B 33.01
Silk Road Medical (SILK) United States $1.380B 0.00
OPKO Health (OPK) United States $1.170B 0.00
Veracyte (VCYT) United States $1.148B 0.00
CryoLife (CRY) United States $1.087B 107.85
Accelerate Diagnostics (AXDX) United States $1.075B 0.00
Pacific Biosciences Of California (PACB) United States $1.015B 0.00
Tactile Systems Technology (TCMD) United States $1.003B 147.97
ORTHOFIX MEDICAL INC (OFIX) United States $0.979B 28.36
Luminex (LMNX) United States $0.958B 125.35
ViewRay (VRAY) United States $0.848B 0.00
Fluidigm (FLDM) United States $0.845B 0.00
Natus Medical (BABY) United States $0.815B 18.87
Mesa Laboratories (MLAB) United States $0.790B 37.14
AxoGen (AXGN) United States $0.789B 0.00
Intersect ENT (XENT) United States $0.766B 0.00
AngioDynamics (ANGO) United States $0.726B 25.32
OrthoPediatrics (KIDS) United States $0.589B 0.00
Quotient (QTNT) Switzerland $0.567B 0.00
Corindus Vascular Robotics (CVRS) United States $0.566B 0.00
Si-Bone (SIBN) United States $0.429B 0.00
GenMark Diagnostics (GNMK) United States $0.386B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.375B 20.10
Accuray (ARAY) United States $0.327B 0.00
RTI Surgical (RTIX) United States $0.310B 38.18
ConforMIS (CFMS) United States $0.309B 0.00
TransEnterix (TRXC) United States $0.287B 0.00
Pulse Biosciences (PLSE) United States $0.256B 0.00
SeaSpine Holdings (SPNE) United States $0.255B 0.00
IRadimed (IRMD) United States $0.223B 42.57
Alphatec Holdings (ATEC) United States $0.221B 0.00
Soliton (SOLY) United States $0.214B 0.00
Neuronetics (STIM) United States $0.212B 0.00
CRH Medical (CRHM) Canada $0.204B 71.25
Sientra (SIEN) United States $0.189B 0.00
Biosig Technologies (BSGM) United States $0.166B 0.00
Ekso Bionics Holdings (EKSO) United States $0.097B 0.00
Second Sight Medical Products (EYES) United States $0.088B 0.00
Apollo Endosurgery (APEN) United States $0.083B 0.00
Sensus Healthcare (SRTS) United States $0.080B 0.00
T2 Biosystems (TTOO) United States $0.078B 0.00
Vermillion (VRML) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.075B 0.00
Helius Medical Technologies (HSDT) United States $0.068B 0.00
Nuvectra (NVTR) United States $0.066B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.062B 0.00
Titan Medical (TMDI) Canada $0.047B 0.00
Electromed (ELMD) United States $0.045B 23.04
Ra Medical Systems (RMED) United States $0.043B 0.00
Xtant Medical Holdings (XTNT) United States $0.039B 0.00
Neovasc (NVCN) Canada $0.036B 0.00
PAVmed (PAVM) United States $0.036B 0.00
Avinger (AVGR) United States $0.029B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.024B 0.00
Microbot Medical (MBOT) United States $0.022B 0.00
Viveve Medical (VIVE) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.021B 0.00
Restoration Robotics (HAIR) United States $0.020B 0.00
DarioHealth (DRIO) Israel $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.017B 18.13
OBALON THERPTCS (OBLN) United States $0.016B 0.00
Nanovibronix (NAOV) United States $0.016B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
ALCON INC (ALC) $0.000B 0.00